American Bio Medica Corporation

ABMC · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$1,410-$463-$796-$681
Dep. & Amort.$51$68$79$81
Deferred Tax-$15$0$160$94
Stock-Based Comp.$0$0$2$6
Change in WC$620-$181-$17$433
Other Non-Cash-$14-$97$89$125
Operating Cash Flow-$768-$673-$483$58
Investing Activities
PP&E Inv.$0$0-$4$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$4$0
Financing Activities
Debt Repay.$687$590$430-$167
Stock Issued$0$100$199$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$48$0
Financing Cash Flow$687$690$581-$167
Forex Effect$0$0$0$0
Net Chg. in Cash-$81$17$94-$109
Supplemental Information
Beg. Cash$115$98$4$113
End Cash$34$115$98$4
Free Cash Flow-$768-$673-$487$58
American Bio Medica Corporation (ABMC) Financial Statements & Key Stats | AlphaPilot